SCHEMBL9813551

SCHEMBL9813551

CN1C(=O)CS/C1=C\C(=O)Nc1c(Cl)cccc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ PSMD14 O00487 1/20 0.50
▸ MAPT P10636 6/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ USP2 O75604 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PDK1 Q15118 1/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ PDK3 Q15120 1/20 0.35
▸ PDK4 Q16654 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ CLK1 P49759 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813552 1.00 ALDH1A1 (0.59) ALDH1A1TDP1PSMD14MAPTMEN1
Ralitoline SCHEMBL635346 0.93 PSMD14 (0.55) ALDH1A1TDP1PSMD14PDK1PDK2
Ralitoline SCHEMBL9813595 0.93 PSMD14 (0.55) ALDH1A1TDP1PSMD14PDK1PDK2
SCHEMBL9813546 0.86 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MAPTGAA
SCHEMBL9813545 0.86 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MAPTGAA
SCHEMBL9813566 0.86 PSMD14 (0.61) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813569 0.86 PSMD14 (0.61) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813544 0.81 ALDH1A1 (0.56) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813543 0.81 ALDH1A1 (0.56) ALDH1A1TDP1PSMD14MAPTMEN1
SCHEMBL9813602 0.81 ALDH1A1 (0.57) ALDH1A1TDP1PSMD14MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP claimed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US claimed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP claimed
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback